January 21, 2015 | Before its anticipated NASDAQ IPO, the Israeli medical device company Check-Cap announced changes to its board of directors. The company, which has developed a non-invasive X-Ray pill for intestinal screening, hopes to raise $15 million in its IPO that was announced last week. The new members of the board include Yuval Yanai, the former CTO at Given Imaging, a Check-Cap competitor that was sold to the Irish company Covidien for almost $1 billion, and Steven J. Hanley, a former president at Covidien and CEO of MediBeacon. Check-Cap was founded in 2005 by Dr. Yoav Kimchy.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments